BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kauppila JH, Mattsson F, Brusselaers N, Lagergren J. Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study. BMJ Open. 2018;8:e021495. [PMID: 29748347 DOI: 10.1136/bmjopen-2018-021495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 van den Ende T, Smyth E, Hulshof MC, van Laarhoven HW. Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer. Best Practice & Research Clinical Gastroenterology 2018;36-37:45-52. [DOI: 10.1016/j.bpg.2018.11.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Luo HS, Xu HY, Du ZS, Li XY, Wu SX, Huang HC, Lin LX. Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis. Radiat Oncol 2019;14:74. [PMID: 31046792 DOI: 10.1186/s13014-019-1278-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Qian H, Ji X, Liu C, Dang Y, Li X, Zhang G. Clinical Characteristics, Prognosis, and Nomogram for Esophageal Cancer Based on Adenosquamous Carcinoma: A SEER Database Analysis. Front Oncol 2021;11:603349. [PMID: 33981595 DOI: 10.3389/fonc.2021.603349] [Reference Citation Analysis]
4 Wu XX, Chen RP, Chen RC, Gong HP, Wang BF, Li YL, Lin XR, Huang ZM. Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis. J Thorac Dis 2019;11:2990-3003. [PMID: 31463129 DOI: 10.21037/jtd.2019.07.56] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Kauppila JH, Johar A, Lagergren P. Medical and Surgical Complications and Health-related Quality of Life After Esophageal Cancer Surgery: . Annals of Surgery 2020;271:502-8. [DOI: 10.1097/sla.0000000000003097] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wang C, Wei H, Li Y. Comparison of fully-covered vs partially covered self-expanding metallic stents for palliative treatment of inoperable esophageal malignancy: a systematic review and meta-analysis. BMC Cancer 2020;20:73. [PMID: 32000719 DOI: 10.1186/s12885-020-6564-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Helminen O, Sihvo E, Gunn J, Sipilä JOT, Rautava P, Kytö V. Trends and results of oesophageal cancer surgery in Finland between 2004 and 2014. European Journal of Cardio-Thoracic Surgery 2020;57:107-13. [DOI: 10.1093/ejcts/ezz189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Mather MW, Wilson JA, Doona M, Talks BJ, Fullard M, Griffin M, Powell J, Drinnan M. The utility of a symptom model to predict the risk of oesophageal cancer. The Surgeon 2022. [DOI: 10.1016/j.surge.2022.03.006] [Reference Citation Analysis]
9 Weygant N, Chang K, Jackson CS, Vega KJ. Sex-Associated Gene Expression Alterations Correlate With Esophageal Cancer Survival. Clin Transl Gastroenterol 2020;12:e00281. [PMID: 33464731 DOI: 10.14309/ctg.0000000000000281] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Schandl A, Mälberg K, Haglund L, Arnberg L, Lagergren P. Patient and public involvement in oesophageal cancer survivorship research. Acta Oncol 2022;61:371-7. [PMID: 34923913 DOI: 10.1080/0284186X.2021.2016950] [Reference Citation Analysis]
11 Junttila A, Väyrynen JP, Ahtiainen M, Kuopio T, Mrena J, Sihvo E, Helminen O. Immune cell score, PD-L1 expression and prognosis in esophageal cancer. Acta Oncol 2021;60:544-8. [PMID: 33438497 DOI: 10.1080/0284186X.2020.1868571] [Reference Citation Analysis]
12 Xie SH, Santoni G, Mälberg K, Lagergren P, Lagergren J. Prediction Model of Long-term Survival After Esophageal Cancer Surgery. Ann Surg 2021;273:933-9. [PMID: 33824250 DOI: 10.1097/SLA.0000000000003431] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ólafsdóttir HS, Klevebro F, Ndegwa N, Alexandersson von Döbeln G. Short-course compared to long-course palliative radiotherapy for oesophageal cancer: a single centre observational cohort study. Radiat Oncol 2021;16:153. [PMID: 34399793 DOI: 10.1186/s13014-021-01880-9] [Reference Citation Analysis]
14 Kauppila JH, Wahlin K, Lagergren P, Lagergren J. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma: Sex and prognosis in esophageal cancer. Int J Cancer 2019;144:1284-91. [DOI: 10.1002/ijc.31840] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
15 Jokela EMK, Kauppila JH; FINEGO group. Preoperative hemoglobin count and prognosis of esophageal cancer, a population-based nationwide study in Finland. Eur J Surg Oncol 2021:S0748-7983(21)00692-2. [PMID: 34420826 DOI: 10.1016/j.ejso.2021.08.020] [Reference Citation Analysis]
16 Burke E, Harkins P, Saeed M, Salama M, Ahmed I. "Dr. Google" Will See You Now-Assessing the Quality of Information on Oesophageal Cancer on the Internet. J Gastrointest Surg 2020;24:2466-70. [PMID: 31768833 DOI: 10.1007/s11605-019-04416-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Onitilo AA, Stankowski-Drengler TJ, Shiyanbola O, Engel J, Tanimu S, Fagbemi SO, Li YH. Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC). Clin Med Res 2021;19:64-71. [PMID: 33789952 DOI: 10.3121/cmr.2021.1573] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Junttila A, Helminen O, Mrena J, Sihvo E. Exercise capacity in the stair-climbing test predicts outcomes of operable esophageal cancer in minimally invasive era. Eur J Surg Oncol 2021:S0748-7983(21)00774-5. [PMID: 34740478 DOI: 10.1016/j.ejso.2021.10.024] [Reference Citation Analysis]
19 Kahn A, Shaheen NJ, Iyer PG. Approach to the Post-Ablation Barrett's Esophagus Patient. Am J Gastroenterol 2020;115:823-31. [PMID: 31899706 DOI: 10.14309/ajg.0000000000000514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sanghi V, Amin H, Sanaka MR, Thota PN. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management. World J Gastrointest Endosc 2019; 11(10): 491-503 [PMID: 31798770 DOI: 10.4253/wjge.v11.i10.491] [Reference Citation Analysis]
21 Chen X, Zhou Y, Xu Q, Pu D, Shu X, Wei G, Qiu M. Clinical Characteristics and Outcome Between Gallbladder Squamous Cell Carcinoma and Adenocarcinoma: A Propensity Matched Analysis Based on the Surveillance, Epidemiology, and End Results Database. Front Oncol 2022;12:833447. [DOI: 10.3389/fonc.2022.833447] [Reference Citation Analysis]
22 Lütken CD, Fiehn AK, Federspiel B, Achiam MP. Impact of isolated tumor cells in regional lymph nodes in adeno-and squamous cell carcinoma of the esophagus and the esophagogastric junction-A systematic review. Pathol Res Pract 2019;215:849-54. [PMID: 30723054 DOI: 10.1016/j.prp.2019.01.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Pickering OJ, Breininger SP, Underwood TJ, Walters ZS. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma. Cancers (Basel) 2021;13:4084. [PMID: 34439236 DOI: 10.3390/cancers13164084] [Reference Citation Analysis]
24 Qiao Z, Dai C, Wang Z, Wang Z, Wang Z, Zhang T, Niu W, Ma X. Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway. Thorac Cancer 2022. [PMID: 35238170 DOI: 10.1111/1759-7714.14366] [Reference Citation Analysis]
25 Cameniţă D, Demetrian AD, Pleşea RM, Tănasie-Vasile MI, Strâmbu VDE, Grigorean VT, Ioniţă E, Pleşea IE, Marincaş AM. Clinical-morphological profiles of esophageal carcinoma's main types. Rom J Morphol Embryol 2020;61:407-22. [PMID: 33544792 DOI: 10.47162/RJME.61.2.10] [Reference Citation Analysis]
26 Helminen O, Mrena J, Sihvo E. Can We Increase the Resection Rate by Minimally Invasive Approach? Experience from 100 Minimally Invasive Esophagectomies. J Oncol 2019;2019:3809383. [PMID: 30915119 DOI: 10.1155/2019/3809383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Wang QL, Lagergren J, Xie SH. Prediction of individuals at high absolute risk of esophageal squamous cell carcinoma. Gastrointest Endosc 2019;89:726-732.e2. [PMID: 30616974 DOI: 10.1016/j.gie.2018.10.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
28 Söderström HK, Räsänen J, Saarnio J, Toikkanen V, Tyrväinen T, Rantanen T, Valtola A, Ohtonen P, Pääaho M, Kokkola A, Kallio R, Karttunen TJ, Pohjanen VM, Ristimäki A, Laine S, Sihvo E, Kauppila JH. Cohort profile: a nationwide population-based retrospective assessment of oesophageal cancer in the Finnish National Esophago-Gastric Cancer Cohort (FINEGO). BMJ Open 2020;10:e039575. [PMID: 33055119 DOI: 10.1136/bmjopen-2020-039575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Jankarashvili N, Melkadze T, Tchiabrishvili M, Mariamidze A, Arveladze G. Advanced Esophageal Squamous Cell Carcinoma in Young Female Patient With Durable Complete Response on Treatment. Cureus 2021;13:e15255. [PMID: 34188993 DOI: 10.7759/cureus.15255] [Reference Citation Analysis]
30 Göbel HH, Büttner-Herold MJ, Fuhrich N, Aigner T, Grabenbauer GG, Distel LVR. Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma. Radiother Oncol 2020;146:151-60. [PMID: 32169773 DOI: 10.1016/j.radonc.2020.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Kauppila JH, Johar A, Lagergren P. Postoperative Complications and Health-related Quality of Life 10 Years After Esophageal Cancer Surgery. Ann Surg 2020;271:311-6. [PMID: 29995688 DOI: 10.1097/SLA.0000000000002972] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
32 Deng W, Yu R, Yang Z, Dong X, Wang W. Trends in conditional overall survival of esophageal cancer: a population-based study. Ann Transl Med 2021;9:102. [PMID: 33569404 DOI: 10.21037/atm-20-2798] [Reference Citation Analysis]
33 Wang H, Tang H, Fang Y, Tan L, Yin J, Shen Y, Zeng Z, Zhu J, Hou Y, Du M, Jiao J, Jiang H, Gong L, Li Z, Liu J, Xie D, Li W, Lian C, Zhao Q, Chen C, Zheng B, Liao Y, Li K, Li H, Wu H, Dai L, Chen KN. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial. JAMA Surg 2021;156:444-51. [PMID: 33729467 DOI: 10.1001/jamasurg.2021.0133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Ignatova EO, Kozlov E, Ivanov M, Mileyko V, Menshikova S, Sun H, Fedyanin M, Tryakin A, Stilidi I. Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma. World J Gastrointest Oncol 2022; 14(3): 628-645 [DOI: 10.4251/wjgo.v14.i3.628] [Reference Citation Analysis]
35 Wang Y, Lyu Z, Qin Y, Wang X, Sun L, Zhang Y, Gong L, Wu S, Han S, Tang Y, Jia Y, Kwong DL, Kam N, Guan XY. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma. Theranostics 2020;10:11535-48. [PMID: 33052231 DOI: 10.7150/thno.45261] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
36 Kauppila JH, Ohtonen P, Karttunen TJ, Kokkola A, Laine S, Rantanen T, Ristimäki A, Räsänen JV, Saarnio J, Sihvo E, Toikkanen V, Tyrväinen T. Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland. BMJ Open 2019;9:e024094. [PMID: 30782726 DOI: 10.1136/bmjopen-2018-024094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Offman J, Pesola F, Fitzgerald RC, Hamilton W, Sasieni P. Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study. Cancer Med 2021. [PMID: 34913599 DOI: 10.1002/cam4.4484] [Reference Citation Analysis]
38 Zhang L, Zhou S, Guo E, Chen X, Yang J, Li X. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling. Pflugers Arch 2020;472:1041-9. [PMID: 32533239 DOI: 10.1007/s00424-020-02415-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]